{"id":"https://openalex.org/W7225145503","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1132","title":"1132 Spatial mapping and significance of the IL-12 pathway in human colorectal cancer","display_name":"1132 Spatial mapping and significance of the IL-12 pathway in human colorectal cancer","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225145503","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1132"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1132","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1132","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1132","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1294.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1294.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160565185","display_name":"Juan Guiza Higuera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan Guiza Higuera","raw_affiliation_strings":["Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132887029","display_name":"Lucy Zheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucy Zheng","raw_affiliation_strings":["Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071618928","display_name":"Luciene Borges","orcid":"https://orcid.org/0000-0002-0499-1919","observed_orcids":["https://orcid.org/0000-0002-0499-1919"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luciene Borges","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069463643","display_name":"Sandra Mart\u00ednez-Morilla","orcid":"https://orcid.org/0000-0003-0931-4906","observed_orcids":["https://orcid.org/0000-0003-0931-4906"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandra Martinez-Morilla","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046249487","display_name":"Jillian M. Prendergast","orcid":"https://orcid.org/0000-0001-7965-4143","observed_orcids":["https://orcid.org/0000-0001-7965-4143"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jillian M Prendergast","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113793741","display_name":"Reniqua P. House","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reniqua House","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039115208","display_name":"Kurt Alex Schalper","orcid":"https://orcid.org/0000-0001-5692-4833","observed_orcids":["https://orcid.org/0000-0001-5692-4833"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurt A Schalper","raw_affiliation_strings":["Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1294","last_page":"A1294"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7300000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.7300000190734863,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.09510000050067902,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.05779999867081642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9639999866485596},{"id":"https://openalex.org/keywords/spatial-mapping","display_name":"spatial mapping","score":0.7739999890327454},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.703000009059906},{"id":"https://openalex.org/keywords/cytokine-signaling","display_name":"cytokine signaling","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6640999913215637},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6173999905586243},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.42480000853538513},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.38609999418258667},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34459999203681946},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.322299987077713},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31380000710487366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3125999867916107},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.27549999952316284},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2590000033378601},{"id":"https://openalex.org/C71472368","wikidata":"https://www.wikidata.org/wiki/Q676880","display_name":"Text mining","level":2,"score":0.2587999999523163}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.1132","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1132","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1132","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1294.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.1132","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.1132","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.1132","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1294.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225145503.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6991739302","https://openalex.org/W2280327500","https://openalex.org/W145642074","https://openalex.org/W1978609023","https://openalex.org/W4404897110","https://openalex.org/W1055466","https://openalex.org/W1995248820","https://openalex.org/W2034192038","https://openalex.org/W2151246643","https://openalex.org/W2564298690"],"abstract_inverted_index":{"Background":[0],"Colorectal":[1],"cancer":[2,239,400],"(CRC)":[3],"has":[4],"the":[5,10,30,67,86,93,119,250,264],"third":[6,155],"highest":[7,12],"incidence":[8,405],"and":[9,48,74,80,89,116,132,160,196,208,226,260,288,309,322,345,366,371,377,403,406,453],"second":[11],"mortality":[13,407],"rate.":[14],"1":[15],"In":[16],"patients":[17,489],"with":[18,192,222,244,272,284,295,325,490],"CRC,":[19],"sensitivity":[20],"to":[21,102,114,434],"immune":[22,45],"checkpoint":[23],"blockers":[24],"(ICB)":[25],"is":[26,56,323,335],"predominantly":[27],"dictated":[28],"by":[29],"presence":[31,277],"of":[32,63,92,140,184,233,263,278,331,342,362,398,431,456,482],"mismatch":[33],"repair":[34,427],"deficiency":[35,428],"(dMMR)":[36],"and/or":[37],"high":[38,289],"microsatellite":[39],"instability":[40],"(MSI-H)":[41],"status.2":[42],"Uncovering":[43],"actionable":[44],"evasion":[46],"pathways":[47],"immunotherapy":[49],"targets":[50],"for":[51],"most":[52,319],"CRCs":[53,234,321,344],"lacking":[54],"dMMR/MSI-H":[55],"a":[57,326,351],"major":[58,209],"unmet":[59],"need.":[60],"Local":[61],"activation":[62,316],"IL-12":[64,94,120,205,265,300,314,363],"signaling":[65],"in":[66,77,96,137,151,182,238,306,318,337,354,401,488],"tumor":[68,127,290,307],"microenvironment":[69],"(TME)":[70],"drives":[71],"prominent":[72],"immunostimulatory":[73],"anti-tumor":[75],"effect":[76],"pre-clinical":[78],"models":[79],"early":[81],"clinical":[82],"trials.3":[83],"4":[84],"Understanding":[85],"expression,":[87],"distribution":[88,198],"biological":[90,352],"significance":[91],"pathway":[95,121,206,266,301,315],"human":[97,485],"CRC":[98,148,159],"could":[99],"be":[100],"used":[101],"support":[103,359],"optimal":[104,360],"therapeutic":[105],"developments.Methods":[106],"We":[107],"established":[108],"multiplexed":[109],"quantitative":[110],"immunofluorescence":[111],"(mQIF)":[112],"panels":[113],"measure":[115],"spatially":[117],"map":[118],"(DAPI/CK/IL12R\u03b21/pSTAT4/CD8),":[122],"tumor-infiltrating":[123],"lymphocytes":[124],"(TILs;":[125],"DAPI/CK/CD8/CD4/CD20),":[126],"associated":[128,221,243,283,294,324,346],"macrophages":[129],"(TAMs;":[130],"DAPI/CK/CD14/CD68/CD206)":[131],"dendritic":[133],"cells":[134,339],"(DCs;":[135],"DAPI/CK/CD11c/XCR1/HLADR)":[136],"consecutive":[138],"sections":[139],"primary":[141,320,343],"tumors":[142,169,185,271,433],"from":[143,340,409],"two":[144],"clinically/molecularly":[145],"annotated":[146],"independent":[147,330],"cohorts":[149],"represented":[150],"tissue":[152,308],"microarrays.":[153],"A":[154],"cohort":[156],"comprising":[157],"paired":[158],"adjacent":[161,310],"non-tumor":[162,311],"colonic":[163,312],"mucosa":[164],"was":[165,180,215,242,268,282,293],"also":[166,171],"included.":[167],"The":[168,276,299],"were":[170,220,304],"studied":[172],"using":[173],"whole":[174],"exome":[175],"DNA":[176],"sequencing.Results":[177],"IL12R\u03b21":[178,218,236,334],"expression":[179,237],"identified":[181],">95%":[183],"(mean":[186],"1045":[187],"\u00b1":[188],"200.8":[189],"cell/mm":[190],"2),":[191],"membranous":[193],"staining":[194],"pattern":[195],"continuous":[197],"across":[199,270],"cases.":[200],"No":[201],"consistent":[202],"association":[203],"between":[204],"markers":[207,267],"clinicopathologic":[210],"variables":[211],"or":[212],"MMR/MSI":[213],"status":[214],"found.":[216],"Elevated":[217],"levels":[219,303],"increased":[223,245,296,347],"CD8+":[224],"TILs":[225],"longer":[227],"3-year":[228],"progression-free":[229],"survival.":[230],"Notably,":[231],"11.1-18.1%":[232],"displayed":[235],"cells,":[240],"which":[241],"pSTAT4":[246],"levels.":[247],"As":[248],"expected,":[249],"top":[251],"mutated":[252],"genes":[253],"included":[254],"APC,":[255],"TP53,":[256],"KRAS,":[257],"FBXW7,":[258],"PTEN":[259],"SMAD4.":[261],"Expression":[262],"comparable":[269,305],"different":[273],"oncogenic":[274],"mutations.":[275],"deleterious":[279],"APC":[280],"mutations":[281],"distinct":[285],"TAM":[286],"subpopulations":[287],"mutational":[291],"burden":[292,397],"DCs":[297],"subsets.":[298],"marker":[302],"mucosa.Conclusions":[313],"occurs":[317],"favorable":[327],"TME":[328],"composition,":[329],"genomic":[332],"alterations.":[333],"expressed":[336],"malignant":[338],"~14%":[341],"STAT4":[348],"signaling,":[349],"suggesting":[350],"role":[353],"cancer.":[355],"These":[356],"results":[357],"can":[358],"development":[361],"directed":[364],"therapies":[365],"patient":[367],"selection":[368],"strategies.Acknowledgements":[369],"YPTS":[370],"YCGA":[372],"cores":[373],"(Yale),":[374],"Pablo":[375],"Vieyra-Garcia":[376],"Antonia":[378],"Geyer":[379],"(Boehringer":[380],"Ingelheim).References":[381],"Morgan":[382],"E,":[383],"Arnold":[384],"M,":[385,393,449,470,474],"Gini":[386],"A,":[387],"Lorenzoni":[388],"V,":[389],"Cabasag":[390],"CJ,":[391],"Laversanne":[392],"et":[394,424,450,477],"al.":[395,425,451,478],"Global":[396],"colorectal":[399],"2020":[402],"2040:":[404],"estimates":[408],"GLOBOCAN.":[410],"Gut.":[411],"2023;72:338\u2013344.Le":[412],"DT,":[413],"Durham":[414],"JN,":[415],"Smith":[416],"KN,":[417],"Wang":[418],"H,":[419],"Bartlett":[420],"BR,":[421,447],"Aulakh":[422],"LK,":[423],"Mismatch":[426],"predicts":[429],"response":[430],"solid":[432],"PD-1":[435],"blockade.":[436],"Science.":[437],"2017;357(6349):409\u2013413.Brunda":[438],"MJ,":[439,468],"Luistro":[440],"L,":[441],"Warrier":[442],"RR,":[443],"Wright":[444],"RB,":[445],"Hubbard":[446],"Murphy":[448],"Antitumor":[452],"antimetastatic":[454],"activity":[455],"interleukin":[457,486],"12":[458,487],"against":[459],"murine":[460],"tumors.":[461],"J":[462],"Exp":[463],"Med.":[464],"1993;178:1223\u20131230.Atkins":[465],"MB,":[466],"Robertson":[467],"Gordon":[469],"Lotze":[471],"MT,":[472],"DeCoste":[473],"DuBois":[475],"JS,":[476],"Phase":[479],"I":[480],"evaluation":[481],"intravenous":[483],"recombinant":[484],"advanced":[491],"malignancies.":[492],"Clin":[493],"Cancer":[494],"Res.":[495],"1997;3:409\u2013417.":[496]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-11-04T00:00:00"}